| Browse All

Oaktree Acquisition Corp. III Life Sciences (OACCW)

Los Angeles, United States | NasdaqGM
0.89 USD +0.05 (5.357%) ⇧ (April 17, 2026, 2:39 p.m. EDT)

Short-term: ☆☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 9, 2026, 12:24 a.m. EDT

OACCW exhibits extreme volatility and lacks any dividend history, making it a high-risk investment. The stock has remained stagnant at $0.75 for an extended period, with no significant price movement. The negative book value, negative return on assets, and negative operating cash flow indicate poor financial health. The forecasting model provides no reliable direction, suggesting that short-term and long-term investment potential is minimal. Avoid this stock unless you are seeking high-risk, speculative opportunities.

None

Info Dump

Attribute Value
Address1 333 South Grand Avenue
Address2 28th Floor
Ask 0.5601
Ask Size 8
Bid 0.88
Bid Size 1
Book Value -0.275
City Los Angeles
Country United States
Crypto Tradeable 0
Currency USD
Current Price 0.885
Current Ratio 1.191
Custom Price Alert Confidence HIGH
Day High 0.885
Day Low 0.885
Ebitda Margins 0.0
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Two Week High 0.885
Fifty Two Week High Change 0.0
Fifty Two Week High Change Percent 0.0
Fifty Two Week Low 0.885
Fifty Two Week Low Change 0.0
Fifty Two Week Low Change Percent 0.0
Fifty Two Week Range 0.885 - 0.885
Financial Currency USD
First Trade Date Milliseconds 1,772,807,400,000
Float Shares 18,370,211
Free Cashflow -86,972
Full Exchange Name NasdaqGM
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Industry
Industry Key
Ipo Expected Date 2,024-12-16
Language en-US
Long Business Summary Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
Long Name Oaktree Acquisition Corp. III Life Sciences
Market us_market
Market State CLOSED
Max Age 86,400
Message Board Id finmb_1890819822
Net Income To Common 7,288,824
Open 0.99
Operating Cashflow -422,079
Operating Margins 0.0
Phone 213 830 6300
Previous Close 0.84
Price Hint 4
Price To Book -3.2181816
Profit Margins 0.0
Quick Ratio 1.104
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.045000017
Regular Market Change Percent 5.3571453
Regular Market Day High 0.885
Regular Market Day Low 0.885
Regular Market Day Range 0.885 - 0.885
Regular Market Open 0.99
Regular Market Previous Close 0.84
Regular Market Price 0.885
Regular Market Time 1,776,451,145
Regular Market Volume 2,511
Return On Assets -0.00375
Sand P52 Week Change 0.38150132
Sector
Sector Key
Short Name Oaktree Acquisition Corp. III L
Source Interval 15
State CA
Symbol OACCW
Total Cash 1,434,965
Total Cash Per Share 0.058
Total Debt 11,824
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Peg Ratio None
Triggerable 1
Type Disp Equity
Volume 2,511
Website https://www.oaktreeacquisitioncorp.com/oac-iii
Zip 90,071